Comparıson of the effectıveness of ıntradıalıtıc Core stabılızatıon and aerobıc exercıse ın hemodıalysıs patıents

Sponsor
Muş Alparlan University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05534542
Collaborator
(none)
40
2
2.2

Study Details

Study Description

Brief Summary

Purpose: To examine the effects of core stabilization and aerobic exercises on dialysis adequacy, functionality level, and quality of life in hemodialysis (HD) patients. The secondary aim of the study is to compare the effectiveness of intradialytic core stabilization and aerobic exercises in HD patients.

Materials and Methods: Patients who received hemodialysis treatment for 4 hours, 3 days a week were planned to be included in this randomized controlled study. Patients participating in the study will be randomly divided into 2 groups. Grup 1 was planned to be given core stabilization exercises during hemodialysis three times a week for eight weeks; Group 2 was planned to be given aerobic exercise during hemodialysis three times a week for eight weeks. It aimed to evaluate the patients in the weeks before the start of the treatment and the week after the end of the treatment. Personal information form for evaluation, dialysis adequacy, quality of life questionnaire-kidney disease quality of life-36, piper fatigue scale, hospital anxiety and depression scale (hads), Pittsburgh sleep scale, five times sit and stand test, 10 m walking test , tinetti balance and walking test, and 2-minute step test were planned to be used.

Condition or Disease Intervention/Treatment Phase
  • Other: exercıse
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparıson of the effectıveness of ıntradıalıtıc Core stabılızatıon and aerobıc exercıse ın hemodıalysıs patıents
Anticipated Study Start Date :
Sep 5, 2022
Anticipated Primary Completion Date :
Sep 9, 2022
Anticipated Study Completion Date :
Nov 11, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: core stabılızatıon

use of ıntradıalıtıc core stabılızatıon ın hemodıalysıs patıents

Other: exercıse
ıntradıalıtıc core stabılızatıon

Active Comparator: aerobıc exercıse

use of ıntradıalıtıc aerobıc exercıse ın hemodıalysıs patıents

Other: exercıse
ıntradıalıtıc core stabılızatıon

Outcome Measures

Primary Outcome Measures

  1. Dialysis adequacy [one month]

    Dialysis adequacy is determined as the urea reduction rate (URR) and unitless Kt/V value. In calculating the Kt/V value; K-is the urea clearance coefficient of the dialyzer (ml/min), t refers to dialysis time (min), and V signifies the urea distribution volume (ml).

  2. Kidney Disease Quality of Life-36 (KDQOL-36) [Two months]

    The KDQOL-36 is a measure of kidney disease-related quality of life that comprises four subscales: generic core [Physical Component Summary (PCS, 12 items) and Mental Component Summary (MCS, 12 items)]; Symptoms/Problems (12 items); Burden of Kidney Disease (4 items), and Effects of Kidney Disease (8 items).

  3. Five times sit-to-stand test [Two months]

    The Five-Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements.

  4. 2 Minute Step Test [Two months]

    The test, known as the 2-minute step test (TMST), simply requires that tested individuals march in place as fast as possible for 2 minutes while lifting their knees to a height midway between their patella and iliac crest when standing.

  5. 10 Metre Walk Test [Two months]

    The 10 meter walk test is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

Secondary Outcome Measures

  1. Piper Fatigue Scale [Two months]

    The Piper Fatigue Scale (PFS) is one of the commonly used multidimensional fatigue measures and includes subdomains of behavioral, affective, sensory, and cognitive/mood attributes of fatigue.

  2. Hospital Anxiety and Depression Scale (HADS) [Two months]

    The HADS was developed to detect states of anxiety and depression in hospitalized patients. The measure was designed to exclude items that might conflate anxiety or depression with physical health problems.

  3. Pittsburgh Sleep Quality Index (PSQI) [Two months]

    PSQI is a self-rated questionnaire that assesses sleep quality and disturbances over a 1-month time interval.

  4. Tinetti Gait and Balance Test [Two months]

    The Tinetti assessment tool is an easily administered, task-oriented test that measures an adult's gait and balance abilities. To assess balance, the patient is seated in a firm, armless chair. stand next to the patient to evaluate the gait. The patient is asked to walk normally and then speed up.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • To receive HD treatment for a minimum of 6 months, for 4 hours per day, three days per week

  • Being 18 years or older

  • A score of 3 and/or below in the Sarcopenia Screening Test (SARC-F)

Exclusion Criteria:
  • Having a history of myocardial infarction in the last 3 months

  • Having angina pectoris, arrhythmia, or uncontrolled hypertension

  • Having communication and/or cognitive issues that prevent them from meeting the requirements of the tests

  • Becoming pregnant or going through infertility treatment

  • Having a psychiatric diagnosis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Muş Alparlan University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Muş Alparlan University
ClinicalTrials.gov Identifier:
NCT05534542
Other Study ID Numbers:
  • cngztaskaya
First Posted:
Sep 9, 2022
Last Update Posted:
Sep 9, 2022
Last Verified:
Sep 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Muş Alparlan University

Study Results

No Results Posted as of Sep 9, 2022